Adriano Mollica,Â Alfonso Carotenuto,Â Ettore Novellino,Â Antonio Limatola, Roberto Costante, Francesco Pinnen,Â Azzurra Stefanucci,Stefano Pieretti,Â Anna Borsodi,Â Reza Samavati,Â Ferenc Zador,Â SÃ¡ndor Benyhe, Peg Davis,Â Frank Porreca, andÂ Victor J. Hruby, ACS Med. Chem. Lett., Article ASAP
Publication Date (Web): July 14, 2014
Copyright Â© 2014 American Chemical Society
Two novel opioid analogues have been designed by substituting the nativeÂ d-Ala residues in position 2,2â€² of biphalin with two residues ofÂ d-penicillamine orÂ l-penicillamine and by forming a disulfide bond between the thiol groups. The so-obtained compound 9Â containingÂ d-penicillamines showed excellent Î¼/Î´ mixed receptor affinities (KiÎ´Â = 5.2 nM;Â KiÎ¼Â = 1.9 nM), together with an efficacious capacity to trigger the second messenger and a very goodÂ in vivo antinociceptive activity, whereas productÂ 10Â was scarcely active. An explanation of the two different pharmacological behaviors of products 9 andÂ 10Â was found by studying their conformational properties.